Experimental analysis shows sAPPalpha limits neurite outgrowth in hippocampal neurons, implicating gababr1a signaling.
Neurite outgrowth is essential for neural circuit formation and is tightly regulated by secreted factors and their receptors. The secreted extracellular domain of the amyloid precursor protein (sAPPalpha) has been shown to modulate neurite outgrowth. Recently, the gamma amino butyric acid receptor type-B subunit 1a (GABABR1a) was identified as an sAPPalpha binding partner that mediates its effects on synaptic transmission. Here, we investigated whether this interaction also regulates neurite outgrowth. In primary hippocampal neurons, the GABABR agonist baclofen reduced axon length; whereas, its antagonist CGP54626 increased axon length in primary hippocampal neurons. Moreover, GABABR1a knockout increased axon length and abolished the effect of baclofen. Application of sAPPalpha reduced axon length, an effect that required the presence of both GABABR1a and the extension domain of sAPPalpha, which mediates its binding to GABABR1a. Similarly, the APP 17mer peptide, which is sufficient to bind GABABR1a and mimic the effects of sAPP on synaptic transmission, reduced axon outgrowth in wildtype but not in GABABR1a-deficient neurons. Together, these findings indicate that the 1a isoform contributes to GABABR-dependent suppression of neurite outgrowth and mediates the inhibitory effect of sAPPalpha on neurite outgrowth.
No takes yet. Share an insight, caveat, or question.
Barber et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: